Target intelligence / Profile preview

Peripheral inflammatory and nociceptive pathways

Molecular classification
Other
01

Overview

Peripheral inflammatory and nociceptive pathways represent the physiological systems responsible for detecting and transmitting pain signals from the periphery to the central nervous system (StatPearls, 2023). These pathways are initiated when nociceptors, specialized high-threshold sensory neurons, respond to noxious mechanical, thermal, or chemical stimuli (Nature Reviews Neuroscience, 2014). Following tissue injury, an inflammatory soup of mediators—including prostaglandins, bradykinin, and protons—is released, which can directly activate or sensitize nociceptors (Journal of Clinical Investigation, 2010). This sensitization leads to a state of hyperalgesia, where the threshold for pain activation is lowered, often contributing to chronic pain conditions (The Lancet, 2011). Pharmacological targeting of these pathways involves a diverse range of agents, such as nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase enzymes and local anesthetics that block voltage-gated sodium channels (British Journal of Pharmacology, 2014). Understanding these pathways is crucial for developing targeted analgesics that minimize central side effects while effectively managing peripheral pain (Nature Reviews Drug Discovery, 2017).

Other names
Peripheral pain pathwaysNociceptive signalingInflammatory pain signalingPeripheral nociception
02

Mechanism of action

Modulation of peripheral sensory neuron excitability and inflammatory mediator activity through the inhibition of enzymes (e.g., COX), blockade of ion channels (e.g., Nav1.7), or antagonism of receptors (e.g., TrkA).

03

Biological functions

Signal transductionImmune responseSensory perceptionPeripheral sensitizationOther
04

Disease associations

InflammationChronic painNeuropathic painOsteoarthritisRheumatoid arthritisOther
05

Safety considerations

Gastrointestinal toxicityCardiovascular riskRenal impairmentSensory loss or paresthesiaMasking of underlying tissue damage
06

Interacting drugs

Ibuprofen

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Nerve growth factor (NGF)Prostaglandin E2 (PGE2)

Beyond the preview

Go deeper on Peripheral inflammatory and nociceptive pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peripheral inflammatory and nociceptive pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call